CareDx, Inc. faces uncertainty with proposed reimbursement changes, but has long-term potential in the $8 billion transplant ...

CareDx Inc (NASDAQ:CDNA) is set to release its Q2 2025 earnings on Aug 6, 2025. The consensus estimate for Q2 2025 revenue is $90.56 million, and the earnings are expected to come in at -$0.10 per ...

CareDx (CDNA) reported $86.68 million in revenue for the quarter ended June 2025, representing a year-over-year decline of 6.1%. EPS of $0.10 for the same period compares to $0.25 a year ago. The ...

CareDx CDNA shares rallied 20.6% in the last trading session to close at $10.09. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session.

AMD has revealed its new CDNA data center GPU architecture for high-performance computing and machine learning as well as its roadmap plans for future EPYC and Ryzen processors over the next few ...

We have isolated a new cDNA encoding HMGS in H. brasiliensis. The full-length hmgs2 consists of 1,916-bp and encodes a protein of 464 amino acids with a predicted molecular mass of 51.27 kDa and an ...

We designate cDNA produced by the Message BOOSTER kit reaction as 'MessageBOOSTER cDNA'. For control reactions, we synthesized cDNA directly from cell lysates without an RNA amplification step.